Artemis Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-7,361
Closed -$4.58M – 289
2021
Q3
$4.58M Buy
+7,361
New +$4.95M 0.04% 236
2017
Q3
– Sell
-9,888
Closed -$1.6M – 222
2017
Q2
$1.6M Sell
9,888
-7,903
-44% -$1.28M 0.04% 204
2017
Q1
$2.75M Buy
17,791
+1,496
+9% +$206K 0.07% 163
2016
Q4
$1.91M Sell
16,295
-8,600
-35% -$981K 0.05% 184
2016
Q3
$2.81M Sell
24,895
-5,629
-18% -$593K 0.08% 155
2016
Q2
$2.83M Hold
30,524
– – 0.08% 169
2016
Q1
$2.39M Sell
30,524
-209
-0.7% -$15.1K 0.06% 169
2015
Q4
$2.24M Buy
30,733
+4,915
+19% +$351K 0.06% 162
2015
Q3
$1.92M Buy
25,818
+13,211
+105% +$946K 0.06% 167
2015
Q2
$809K Buy
12,607
+2,895
+30% +$200K 0.03% 190
2015
Q1
$750K Sell
9,712
-2,912
-23% -$227K 0.03% 200
2014
Q4
$936K Buy
+12,624
New +$885K 0.04% 185

Other funds holding IDXX

Artemis Investment Management's IDXX Position: Q4 2021 in Review

Artemis Investment Management sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 7,361 shares — an estimated $4.58M sold.

Artemis Investment Management first reported a position in IDXX in Q4 2014 and held it in 12 quarters. The position peaked at $4.58M in Q3 2021. 1,106 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

  • Artemis Investment Management reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
  • Artemis Investment Management sold 7,361 Idexx Laboratories shares in Q4 2021, an estimated $4.58M.
  • Artemis Investment Management first reported a position in Idexx Laboratories in Q4 2014 and held it in 12 quarters.
  • Artemis Investment Management's Idexx Laboratories position peaked at $4.58M in Q3 2021.
  • 1,106 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on Artemis Investment Management's 13F filing for Q4 2021, filed 8 Feb 2022.